Woodline Partners »

Intra Cellular Therapies shares owned by Woodline Partners

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Woodline Partners

Quarter filed Position value Share count Share price at filing
2025-03-31 $16M 124k 131.92
2023-09-30 $62M 1.2M 52.09
2023-06-30 $12M 193k 63.32
2022-12-31 $21M 392k 52.92
2022-09-30 $13M 288k 46.53
2022-06-30 $7.3M 127k 57.08
2021-03-31 $10M 294k 33.93
2020-12-31 $10M 325k 31.80

More positions owned by Woodline Partners

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
At&t (T)
Chubb (CB)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Keysight Technologies (KEYS)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Merus N V (MRUS)
Autodesk (ADSK)

View all positions for Woodline Partners

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies